MYIA
GILD icon

Mount Yale Investment Advisors’s Gilead Sciences GILD Stock Holding History

Mount Yale Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
27,671
+2,545
+10% +$335K 0.06% 288
2026
Q1 		$3.5M Buy
25,126
+19,758
+368% +$2.77M 0.08% 249
2025
Q4 		$659K Buy
5,368
+3,141
+141% +$382K 0.03% 391
2025
Q3 		$247K Buy
2,227
+1,226
+122% +$139K 0.02% 566
2025
Q2 		$111K Buy
+1,001
New +$107K 0.01% 634
2022
Q4 		– Sell
-119,749
Closed -$7.39M – 473
2022
Q3 		$7.39M Buy
119,749
+10,154
+9% +$640K 0.98% 11
2022
Q2 		$6.77M Buy
109,595
+3,596
+3% +$223K 0.85% 15
2022
Q1 		$6.3M Buy
+105,999
New +$6.78M 0.69% 26
2018
Q4 		– Sell
-4,559
Closed -$330K – 493
2018
Q3 		$330K Sell
4,559
-5,287
-54% -$399K 0.06% 237
2018
Q2 		$697K Buy
9,846
+5,132
+109% +$362K 0.13% 138
2018
Q1 		$355K Buy
+4,714
New +$375K 0.08% 228

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mount Yale Investment Advisors's GILD Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $335K and bringing the position to 27,671 shares worth $3.5M. The position accounts for 0.06% of the portfolio, ranked #288.

Mount Yale Investment Advisors first reported a position in GILD in Q1 2018 and has held it in 11 quarters since. The position peaked at $7.39M in Q3 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mount Yale Investment Advisors held 27,671 shares of Gilead Sciences worth $3.5M as of Q2 2026.
  • Mount Yale Investment Advisors bought 2,545 Gilead Sciences shares in Q2 2026, an estimated $335K.
  • Gilead Sciences made up 0.06% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #288 holding.
  • Mount Yale Investment Advisors first reported a position in Gilead Sciences in Q1 2018 and has held it in 11 quarters since.
  • Mount Yale Investment Advisors's Gilead Sciences position peaked at $7.39M in Q3 2022.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.